+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), ???? (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Forecast 2024-2030- Product Image
Global Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), ???? (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Forecast 2024-2030- Product Image
Sale

Global Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), ???? (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5924676
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Trial Supplies Market size was estimated at USD 3.35 billion in 2023, USD 3.64 billion in 2024, and is expected to grow at a CAGR of 8.43% to reach USD 5.92 billion by 2030.

Clinical trial supplies are a fundamental yet complex component of clinical research, ultimately helping pave the way toward successful therapeutic breakthroughs and monumental enhancements in patient care pathways. These supplies cater to various research phases, from pre-clinical examinations to post-marketing surveillance studies, thus facilitating the seamless management and execution of clinical investigations. The increasing prevalence of infectious and chronic diseases worldwide and the subsequent rise in clinical trials with research and development expenditure of the pharmaceutical and biopharmaceutical industry stimulates market growth.

The high cost associated with clinical trial supplies, stringent regulations for supplies, and cross-border logistics challenges restrict market growth. Growing emphasis on drug development and shifting towards patient-centric clinical trials offer the potential for better clinical trial patient recruitment, study enrollment, and participant retention. In addition, ongoing advancements in a diverse range of clinical trial supplies are expected to open new research avenues for pharmaceutical and biopharmaceutical companies.

Regional Insights

In the Americas, primarily the United States and Canada, there is a significant dependence on clinical trial supplies due to a high diagnosis rate of chronic diseases and robust healthcare infrastructure. Over the past year, the major patents registered revolved around optimizing supply chain models and employing advanced analytics to align trial supply with demand. The European Union (EU), the Middle East, and Africa exhibit a diverse range of needs due to discrepancies in healthcare access and spending. Europe witnesses steady demand for clinical trial supplies, fueled by heavy investments in research and development initiatives and a surge in the geriatric population.

In contrast, Middle Eastern and African countries encompass emerging markets with rising research activities yet laid back due to limited funding and infrastructural impediments. Asia-Pacific, including China, Japan, and India, reports a high disease prevalence, bridged by substantial investments in improving healthcare infrastructure. The booming pharmaceutical industry drives the clinical trial supplies market in these regions, and the demand is dictated more by cost-efficacy rather than speed, mirroring their unique healthcare economic dynamics.

Market Trends by Segment

  • Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
  • Туре: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
  • Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
  • Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
  • End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal

Permira, a UK private equity firm, agreed to acquire Ergomed for USD 888.1 million. Ergomed is a clinical trial development and management services provider, catering to clients across more than 100 countries. This strategic acquisition can expand Permira's already impressive portfolio of medical companies, including Neurapharm and Cambrex.

Thermo Fisher Scientific Launches New Smart Refrigerator Series

Thermo Fisher Scientific introduced the Thermo Scientific TM TSG series refrigerators, specifically engineered to cater to the stringent demands of diverse industries. These cutting-edge refrigerators leverage advanced technology to ensure accurate temperature control, effectively preserving the integrity of vaccines and pharmaceuticals. By minimizing temperature fluctuations, these refrigerators effectively mitigate the risks associated with such variations, safeguarding medical products' potency and efficacy.

Loftware and Tenthpin Collaborate on Clinical Supply Labeling

Loftware and Tenthpin collaborated to launch a software called Loftware Prisym 360, which is specifically designed for clinical supply labeling. The main objective of this partnership is to address the growing challenges faced by clinical trial supply teams within the pharmaceutical industry. This agreement enables both Loftware and Tenthpin to actively promote, educate, and implement a comprehensive content and labeling solution for their clinical customers.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Almac Group Limited, B. Braun SE, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cardinal Health, Inc., Charles River Laboratories, Inc., COREX LOGISTICS LIMITED, Emsere B.V by Medicapital Holdco B.V., Eppendorf SE, Evident Corporation by Olympus Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Group, Hipro Biotechnology Co., Ltd., Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Immudex ApS, Incyte Corporation, IQVIA Inc., Johnson & Johnson Services, Inc., KLIFO A/S, Labnet International, Leica Microsystems GmbH by Danaher Corporation, llumina, Inc., Lonza Group Ltd., Medline Industries, LP, Merck KGaA, Myonex, LLC, Novo Nordisk A/S, Nuvisan GmbH, Parexel International Corporation, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, PerkinElmer Inc. by Revvity, Inc., Pfizer Inc., Promega Corporation, Recipharm AB, Rubicon Research Pvt. Ltd., Sekisui Diagnostics Group, Sharp Services, LLC, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific Inc., and Woodley Equipment Company Ltd.

This research report offers invaluable insights into various crucial aspects of the Clinical Trial Supplies Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
5.1.2. Restraints
5.1.2.1. High cost of clinical trial supplies
5.1.3. Opportunities
5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
5.1.4. Challenges
5.1.4.1. Stringent regulations for clinical trial supplies
5.2. Market Segmentation Analysis
5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
5.2.2. ????: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
5.3. Market Trend Analysis
5.3.1. Well-established pharmaceutical companies emphasis on increasing the number of clinical trials, propelling the need for clinical trial supplies in the Americas
5.3.2. Expanding government initiatives to strengthen the clinical trial capabilities coupled with supportive regulations and standards in the APAC region
5.3.3. Increasing number of clinical trials and strong and advanced pharmaceutical sector in the EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Clinical Trial Supplies Market, by Phase
6.1. Introduction
6.2. Phase I
6.3. Phase II
6.4. Phase III
6.5. Phase IV
7. Clinical Trial Supplies Market, by ????
7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small-Molecules
8. Clinical Trial Supplies Market, by Product
8.1. Introduction
8.2. Auxiliary Medicinal Products
8.3. Interactive Response Technology (IRT) solutions
8.4. Lab Supplies
8.5. Medical Devices & Diagnostics
8.6. Pharmacy Supplies
8.7. Research Materials
8.8. Safety Equipment
9. Clinical Trial Supplies Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiology
9.3. Genetic Diseases
9.4. Immunology
9.5. Infectious Diseases
9.6. Metabolic Disorders
9.7. Neurology
9.8. Oncology
10. Clinical Trial Supplies Market, by End User
10.1. Introduction
10.2. Contract Research Organisations
10.3. Pharmaceutical & Biotechnology Companies
11. Americas Clinical Trial Supplies Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Clinical Trial Supplies Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Clinical Trial Supplies Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
14.3.2. Thermo Fisher Scientific Launches New Smart Refrigerator Series
14.3.3. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
14.3.4. Sitero Acquires Clario’s eClinical Technology Suite to Enhance Clinical Trial Delivery
14.3.5. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
14.3.6. BD Launches New Robotic System to Automate Clinical Flow Cytometry
14.3.7. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
14.3.8. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
14.3.9. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
14.3.10. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords
14.3.11. Experic Closes USD 14 Million Series B Financing
14.3.12. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. CLINICAL TRIAL SUPPLIES MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL TRIAL SUPPLIES MARKET DYNAMICS
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 83. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 84. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 85. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 86. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 91. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 92. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 93. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 94. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 95. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 96. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 97. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 98. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 99. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 100. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 101. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 104. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 105. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 106. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 107. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 108. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 109. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 110. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 111. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 112. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 113. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 114. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 115. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 116. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 117. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 118. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 119. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 120. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 121. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 122. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 123. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 124. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 125. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 126. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 127. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 128. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 129. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 132. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 133. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 134. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 135. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 136. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 137. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 138. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 139. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 140. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 141. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 142. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 143. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 146. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 147. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 148. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 149. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 150. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 151. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 152. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 153. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 154. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 155. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 156. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 157. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 160. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 161. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 162. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 163. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 164. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 165. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 166. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 167. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 168. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 170. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 172. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 174. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 176. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 178. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 180. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 182. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 184. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 185. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 186. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 187. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 188. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 189. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 190. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 191. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 192. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 193. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 194. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 195. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 196. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 197. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 198. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 199. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 200. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 201. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 202. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 203. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 206. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 207. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 208. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 209. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 210. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 211. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 212. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 213. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 214. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 215. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 216. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 217. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 220. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 221. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 222. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 223. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 224. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 225. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 226. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 227. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 228. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 229. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 230. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 231. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 234. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 235. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 236. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 237. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 238. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 239. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 240. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 241. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 242. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 243. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 244. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 245. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 248. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 249. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 250. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 251. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 252. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 253. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 254. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 255. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 256. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 257. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 258. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 259. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 262. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 263. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 264. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 265. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 266. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 267. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 268. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 269. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 270. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 271. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 272. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 273. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 274. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 275. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 276. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 277. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 278. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 279. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 280. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 281. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 282. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 283. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 284. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 285. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 286. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 287. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 288. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 289. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 290. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 291. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 292. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 293. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 294. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 295. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 296. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 297. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 298. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 299. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 300. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 301. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 302. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 303. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 304. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 305. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 306. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 307. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 308. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 310. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 311. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 312. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 313. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 314. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 315. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 318. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 319. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 320. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 321. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 322. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 323. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 324. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 325. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 326. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 327. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2018-2023 (USD MILLION)
TABLE 328. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2024-2030 (USD MILLION)
TABLE 329. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 330. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 331. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
TABLE 332. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
TABLE 333. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
TABLE 334. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
TABLE 335. THAIL

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Almac Group Limited
  • B. Braun SE
  • Baxter International, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cardinal Health, Inc.
  • Charles River Laboratories, Inc.
  • COREX LOGISTICS LIMITED
  • Emsere B.V by Medicapital Holdco B.V.
  • Eppendorf SE
  • Evident Corporation by Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Group
  • Hipro Biotechnology Co., Ltd.
  • Hitachi, Ltd.
  • HORIBA, Ltd.
  • ICON PLC
  • Immudex ApS
  • Incyte Corporation
  • IQVIA Inc.
  • Johnson & Johnson Services, Inc.
  • KLIFO A/S
  • Labnet International
  • Leica Microsystems GmbH by Danaher Corporation
  • llumina, Inc.
  • Lonza Group Ltd.
  • Medline Industries, LP
  • Merck KGaA
  • Myonex, LLC
  • Novo Nordisk A/S
  • Nuvisan GmbH
  • Parexel International Corporation
  • Perceptive Informatics LLC and its affiliates, d/b/a Calyx
  • PerkinElmer Inc. by Revvity, Inc.
  • Pfizer Inc.
  • Promega Corporation
  • Recipharm AB
  • Rubicon Research Pvt. Ltd.
  • Sekisui Diagnostics Group
  • Sharp Services, LLC
  • Siemens Healthcare GmbH
  • Smith & Nephew PLC
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Woodley Equipment Company Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.92 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned49

Related Topics

Related Reports

Global Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report by Service (Logistics & Distribution, Storage & Retention), Phase, Therapeutic Area, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report by Service (Logistics & Distribution, Storage & Retention), Phase, Therapeutic Area, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 137 Pages
  • Global
From
Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2024-2030 - Product Image

Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Forecast 2024-2030 - Product Image

Global Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023-2030 - Product Image

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 123 Pages
  • Global
From
Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Forecast to 2028 - Product Image

Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Forecast to 2028

  • Report
  • 328 Pages
  • Global
From

About the Clinical Trial Supplies Market

The Clinical Trial Supplies market is a subset of the Pharmaceuticals industry, focused on the production and distribution of materials used in clinical trials. These supplies can include drugs, medical devices, and other materials used to test the safety and efficacy of new treatments. Clinical trial supplies must meet strict regulatory requirements, and must be manufactured and distributed in a way that ensures the integrity of the trial results. The Clinical Trial Supplies market is highly competitive, with a number of companies offering a range of services. These include contract manufacturing organizations, packaging and labeling companies, and logistics providers. Companies in the market include Almac Group, Fisher Clinical Services, and PCI Pharma Services. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.